| 2024/05/02 17:35:20 | |
|---|---|
| Price | |
| 2.51 EUR | |
| Difference | -2.52% (-0.07) |
General attributes
| ISIN | NL0012047823 |
| Symbol | AVTX |
| Exchange | Euronext Amsterdam |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 200 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | 2.50 EUR (7,975) |
| Ask (Ask size) | 2.60 EUR (4,600) |
| Open | 2.585 EUR |
| High | 2.615 EUR |
| Low | 2.505 EUR |
| Close (prev. day) | 2.575 EUR |
| VWAP | 2.564158 EUR |
| Volume (pcs) | 256,356 |
| Trading volume | 657,337.00 |
| Number of trades | 340 |
| Last size | 201 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: AVANTIUM NV |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/05/02 17:35:20 | |
|---|---|
| Price | |
| 2.51 EUR | |
| Difference | -2.52% (-0.07) |
General attributes
| ISIN | NL0012047823 |
| Symbol | AVTX |
| Exchange | Euronext Amsterdam |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 200 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | 2.50 EUR (7,975) |
| Ask (Ask size) | 2.60 EUR (4,600) |
| Open | 2.585 EUR |
| High | 2.615 EUR |
| Low | 2.505 EUR |
| Close (prev. day) | 2.575 EUR |
| VWAP | 2.564158 EUR |
| Volume (pcs) | 256,356 |
| Trading volume | 657,337.00 |
| Number of trades | 340 |
| Last size | 201 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -8.23% | -14.76% | -40.67% |
| Perf (abs.) | -0.23 | -0.43 | -1.72 |
| Beta | 0.51 | 0.75 | 0.96 |
| Volatility | 51.83 | 41.74 | 47.78 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 2.54 EUR (296,107) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 2.32 EUR (523,284) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 2.56 EUR (514,776) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 2.76 EUR (302,631) |
| YTD High | date | 3.15 EUR (2024/01/29) |
| YTD Low | date | 2.00 EUR (2024/04/03) |
| 52 Weeks High | date | 3.89 EUR (2023/11/23) |
| 52 Weeks Low | date | 2.00 EUR (2024/04/03) |
All listings for AVANTIUM NV
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/05/02 | 22:26 | 2.52 EUR | 0.01 | 7 |
| Stuttgart | 2024/05/02 | 15:27 | 2.535 EUR | 0.00 | 9 |
| Munich | 2024/05/02 | 08:10 | 2.575 EUR | 0.00 | 1 |
| London Stock Exchange | 2023/03/09 | 15:46 | 4.30 EUR | 0.00 | 1 |
| Frankfurt | 2024/05/02 | 17:20 | 2.50 EUR | 0.00 | 6 |
| FINRA other OTC Issues | 2024/05/02 | 17:51 | 2.75 USD | 0.01 | 2 |
| Euronext Amsterdam | 2024/05/02 | 17:35 | 2.51 EUR | 0.66 | 340 |
| Duesseldorf | 2024/05/02 | 19:30 | 2.46 EUR | 0.00 | 6 |
| Berlin | 2024/05/02 | 21:50 | 2.515 EUR | 0.00 | 18 |
Company Logo
Contact Details
| AVANTIUM NV |
| - - |
| Zekeringstraat 29 - 1014 BV Amsterdam |
| Telefon: +31-20-586-80-80 |
| Fax: +31-20-586-80-85 |
| E-mail: info@avantium.com |
PDF Downloads
| Company report: AVANTIUM NV | |
Company Profile
Avantium NV engages in the development and commercialization of bio-based plastics and chemicals using advanced catalysis research and development. It operates through the following segments: R&D Solutions, Renewable Chemistries, and Renewable Polymers. The R&D Solutions segment provides advanced catalysis research and development services, systems, and testing to global customers. The Renewable Chemistries segment develops PlantMEG, a plant-based alternative for fossil-based mono-ethylene glyco. The Renewable Polymers segment focuses on the commercialization of YXY plants-to-plastics technology. The company was founded February 2000 and is headquartered in Amsterdam, the Netherlands. |
Members of Management Board
| Tom van Aken | Chairman of Managing Board |
| Boudewijn van Schaik | Member of Executive Committee |
Board of directors
| Edwin Moses | Chairman of Supervisory Board |
| Dirk van Meirvenne | Member of Supervisory Board |
| Margret Kleinsman | Member of Supervisory Board |
| Michelle Jou | Member of Supervisory Board |
| Nils Björkman | Member of Supervisory Board |
| Peter Williams | Member of Supervisory Board |